(Q48563316)

12 February 2018

title

Acute reserpine administration elicits long-term spontaneous oral dyskinesia. (English)

1 reference

12 February 2018

1 reference

3

1 reference

12 February 2018

author name string

Sussman AN

series ordinal

1

1 reference

12 February 2018

Tran-Nguyen LT

series ordinal

2

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

12 February 2018

European Journal of Pharmacology

published in

1 reference

12 February 2018

volume

337

1 reference

12 February 2018

issue

2-3

1 reference

12 February 2018

page(s)

157-160

1 reference

12 February 2018

Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

The pharmacology of tardive dyskinesias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901271-5

10.1016/S0014-2999(97)01271-5

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018